Related Experiment Video
Updated: Jun 20, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Intracellular innate immune cascades and interferon defenses that control hepatitis C virus
1Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98195, USA.
Insights
Hepatitis C virus (HCV) evades the host immune system by suppressing the RIG-I pathway and interferon production. Understanding these viral evasion strategies is key to developing new therapies that reactivate the immune response against chronic HCV infection.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) causes chronic infection in nearly 200 million people globally.
- HCV establishes persistent infections due to host immune system inefficiencies and viral evasion tactics.
- HCV evades innate immunity by suppressing the RIG-I pathway and interferon production in hepatocytes.
Purpose of the Study:
- To review the virus and host factors regulating the RIG-I pathway during HCV infection.
- To elucidate mechanisms of HCV immune evasion.
- To identify potential therapeutic targets for reactivating host immunity against HCV.
Main Methods:
- Literature review of viral and host interactions.
- Analysis of immune evasion strategies employed by HCV.
- Examination of the RIG-I signaling pathway in the context of HCV infection.
Main Results:
- HCV actively suppresses the RIG-I pathway, a critical component of innate antiviral immunity.
- Suppression of RIG-I and subsequent interferon production facilitates viral persistence.
- HCV employs specific evasion strategies to counteract host defenses within infected cells.
Conclusions:
- Understanding HCV's regulation of the RIG-I pathway is crucial for combating chronic infection.
- Targeting HCV-host interactions offers a promising avenue for novel therapeutic strategies.
- Reactivating the host immune response holds potential for effective HCV treatment.
Abstract:
Hepatitis C virus (HCV) is a global public health problem that mediates a persistent infection in nearly 200 million people. HCV is efficient in establishing chronicity due in part to the inefficiency of the host immune system in controlling and counteracting HCV-mediated evasion strategies. HCV persistence is linked to the ability of the virus to suppress the RIG-I pathway and interferon production from infected hepatocytes, thus evading innate immune defenses within the infected cell. This review describes the virus and host processes that regulate the RIG-I pathway during HCV infection. An understanding of these HCV-host interactions could lead to more effective therapies for HCV designed to reactivate the host immune response following HCV infection.
Related Concept Videos
Hepatitis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction
Viruses with RNA Genomes
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

